BROS Insider Notice: 178,351 Founders Shares Listed for Sale via Morgan Stanley
Rhea-AI Filing Summary
Dutch Bros Inc. (BROS) notice reports a proposed sale under Rule 144 of 178,351 common shares through Morgan Stanley Smith Barney with an aggregate market value of $11,225,411.94. The filing shows these were acquired as founders shares on 09/27/2018 and payment was recorded as N/A at acquisition. The form lists recent related sales dated 05/22/2025 totaling 722,841 shares (159,254 and 563,587) with gross proceeds of $10,641,830.04 and $37,660,574.10, respectively. The issuer has 126,960,284 shares outstanding, making the proposed sale roughly 0.14% of outstanding shares. The signer certifies no undisclosed material adverse information and, if applicable, reliance on a Rule 10b5-1 plan is noted.
Positive
- Full acquisition history provided: the filing specifies acquisition date (09/27/2018) and nature (Founders Shares), supporting traceability.
- Broker and execution details included: Morgan Stanley Smith Barney is named, giving clear execution channel for the proposed sale.
- Certifies no undisclosed material information: signer represents absence of material nonpublic information and notes Rule 10b5-1 reliance procedures.
Negative
- Significant recent insider sales: prior 10b5-1 sales on 05/22/2025 total 722,841 shares with aggregate gross proceeds of about $48.3 million, which may attract investor attention.
- Large dollar value: the proposed sale value ($11.23 million) is material in absolute terms even if small relative to outstanding shares.
Insights
TL;DR: Insider-related sale of founders shares is modest relative to outstanding stock and follows prior 10b5-1 program disposals.
The filing documents a proposed Rule 144 sale of 178,351 shares valued at $11.2 million, acquired as founders shares in 2018. Recent 10b5-1 sales on 05/22/2025 show larger dispositions totaling 722,841 shares for roughly $48.3 million in gross proceeds. Relative to 126.96 million shares outstanding, the current notice represents approximately 0.14% dilution, indicating the sale is unlikely to materially affect market supply alone. Still, clustered sales under 10b5-1 may warrant monitoring for timing and signaling to the market.
TL;DR: Disclosure aligns with Rule 144 requirements and includes representation about material nonpublic information and possible 10b5-1 reliance.
The form provides required acquirer and acquisition details: founders shares dated 09/27/2018 and broker information (Morgan Stanley Smith Barney). It also includes the mandatory certification about no undisclosed material adverse information and references plan adoption/instruction dates when relying on Rule 10b5-1. Documentation appears procedurally complete for a Rule 144 notice, supporting transparency for investor oversight.